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Introduction
Carcinoid tumours are derived from enterochromaffin cells. Traditionally, they are classified by their site of origin into foregut. midgut and hindgut tumours. 1 Tumours of clinical importance are uncommon. with an annual incidence in England of 7·1 and 8·7 per 10 6 population. for men and women respectlvely-' Carcinoid tumours produce a variety of physiologically active substances. including serotonin. tachyklnins, prostaglandins and bradykinins. These substances may give rise to the carcinoid syndrome. which is characterized by symptoms of flushing and diarrhoea.' Abdominal pain. bronchial asthma. heart failure and pellagra may also be present. Carcinoid syndrome. however. is usually only associated with midgut tumours that have © 2002 The Association of Clinical Biochemists metastasized to the liver. Midgut tumours account for the majority of carcinoid tumours and are found predominantly in the ileum and appendix. Foregut tumours occur primarily in the lung and stomach and rarely present with carcinoid syndrome. although histamine release from stomach carcinoids may result in a characteristic facial flush. Hindgut tumours are found in the rectum and colon but do not produce serotonin and do not cause carcinoid syndrome. ' The laboratory investigation of suspected carcinoid syndrome involves the measurement of the major metabolite of serotonin. 5-hydroxyindole acetic acid . in 24-h urine collections. However. 24-h urine collections are often unreliable due to collection problems and prove unpopular with both patients and laboratory staff. Alternative tests for carcinoid syndrome include whole blood serotonin, which has been suggested to be the most sensitive and specific assay for diagnosis of carcinoid dtsease."
We recently described a method for the measurement of 5-HIAA in plasma by high-performance liquid chromatography (HPLC).f> This assay has now been further evaluated by comparison with both 24-hour urine 5-HIAA and whole blood serotonin measurements in the investigation of carcinoid disease.
Materials and methods

Subjects
Blood and urine samples were obtained from 26 patients (12 men, 14 women) with known carcinoid disease (2 foregut, 24 midgut) confirmed by histological investigation. Control samples were obtained from a group of 31 patients (15 men, 16 women) who presented with symptoms suggestive of carcinoid syndrome. This latter group were shown not to have carcinoid disease by clinical follow-up. This study was approved by the local Research Ethics Committee.
A reference range for plasma 5-HIAA concentration was determined using fasting samples from 43 healthy volunteers (14 men, 29 women) with ages ranging from 24 to 70 years. Reference data for whole blood serotonin concentration were based upon 139 samples (59 men, 80 women. age range 7 to 95 years) obtained from medical outpatient clinics. Any samples with an abnormal platelet count were excluded. The reference range used for 24-h urine 5-HIAA excretion was that previously determined by this laboratory based upon 151 samples «40 Ilmol/24 h).
Sample type
Whole blood for serotonin concentration assay was collected into potassium EDTA and frozen at -20°C within 2 h of phlebotomy. A simultaneous EDTA blood sample was required for a platelet count. Plasma samples for 5-HIAA concentration assay were obtained from heparinized blood following an overnight fast. The samples were separated within 5 h of blood collection and stored at -20 nC until analysis. Creatinine concentration was measured on all plasma samples used in this study. Any subjects with renal impairment were excluded due to the possibility that this may result in decreased excretion of 5-HIAA. Twenty-four hour urine samples for 5-HIAA were collected into 2-L bottles containing glacial acetic acid (25 ml.). Patients were asked to avoid serotonincontaining foods before and during the collection period. The urine samples for 5-HIAA were stored at 4°e. Quality control material for plasma and whole blood analysis was prepared in-house by spiking pooled plasma with 5-HIAA and whole blood with serotonin. The material was aliquoted and stored at -20°e. The quality control material for urine 5-HIAA was obtained from BioRad Laboratories Ltd.
Blood serotonin assay
This method was adapted from that developed by Kwarts et at? Internal standard (5-MT, SOO ilL, 882 mmol) was added to 500 ilL of blood and the resulting solution sonicated for 10 min. An aliquot (500 ilL) of this mixture was applied to a weakly acidic amberlite cation exchange resin. Prior to use the resin was washed and re-suspended in 0·2 mmol/L ammonium acetate and the pH was adjusted to 7·5 with ammonia. The resulting slurry was poured into the column to give a bed 2 em deep and primed with 0·02 mmol/L ammonium acetate. pH 7 ,5. Following application of the sample the column was washed with 0·02 mmol/L ammonium acetate followed by 0·01 mmol/L acetic acid. The serotonin and 5-MT were then eluted from the column with 1 mmol/L acetic acid (3 x 5 mL) containing 4% w!» ascorbic acid. A SO-ilL aliquot of the eluent was injected onto the HPLC column at a flow rate of 0'7 mL/min. The serotonin and 5-MT were separated isocratically and measured by fluorescence detection (excitation 292 nm. emission 337 nm). The mobile phase used was 0·1 mmol/L ammonium acetate containing 0·3 gil octane sulphonic acid, pH4'O, acetonitrile (6% v/v) and methanol (29% v/v).
The assay was standardized using a two-point calibration with aqueous standards of 5-hydroxytryptamine creatinine sulphate (1875 and 3750 nmol/ L, respectively).
Urine 5-HIAA assay
Urine 5-HIAA was measured according to the method developed by Skrinska and Hahn." Fifty microlitres of internal standard (5-HICA, 0'68 mmol/L) and 50 pL of urine sample were added to 500 pL of 0'2% acetic acid. A 50 pL aliquot of this mixture was injected onto the HPLC column using a mobile phase of O'Lmmol/L ammonium acetate, pH 4'55, containing 7·5% v/v acetonitrile at a flowrate of 1· 0 mL/min. 5-HIAA and 5-HICA were measured using fluorescence detection at excitation of 295 nm and emission at 345 nm. The assay was calibrated using a 50 pmol/L aqueous standard of 5-HIAA.
Plasma 5-HIAA assay
A 100-IlL aliquot of internal standard (5-HICA, 13·6 pmol/L) was added to 500 pL of plasma and diluted with 1 mL of water. The resulting solution was acidified with 25 ilL of 50 0A, glacial ascetic acid and saturated with 1 g of sodium chloride. The 5-HIAA and 5-HICA were extracted with 3 mL of dlethyl ether. containing 1 ppm pyrogallol. The ether extract was evaporated under nitrogen at 39°C and the residue reconstituted in 500 pL of mobile phase (0'1 mmol/L ammonium acetate, pH 4,55, containing 3% v/v acetonitrile). A 50-pL aliquot was injected onto the HPLC column at a flow rate of I: 0 mL/min and the 5-HIAA and 5-HICA were separated by gradient elution. The gradient was achieved by increasing the proportion of acetonitrile to 7% over the first 10 min then holding for a period of 8 min. The 5-HIAA and 5·HICA were detected using native fluorescence. detected at excitation of 280 nm and emission at 345 nm. The assay was calibrated using fasting pooled plasma spiked with 5-HIAA to provide four standards in the range ofIOO to 800 nrnol/L,
Investigation of stability of blood serotonin and plasma 5-HIAA
The effect of storage time on the stability of plasma 5-HIAA was investigated on seven samples (two carcinoid, five normals). Plasma 5-HIAAwas measured on day one and day seven after storage at 4 DC. The stability of blood serotonin was investigated with and without preservatives at various temperatures. Freshly collected EDTA blood was split into three aliquots. Two of the aliquots were preserved with sodium metabisulphite (10 mg per 3 mL blood) and 20 pL of reduced glutathione/EGTA solution, respectively, with the third acting as the control. All three aliquots were then split into three parts and stored at -20 DC, 4 DC and room temperature, respectively. The glutathione/EGTA mixture consisted of 4·75 g EGTA and 3 g reduced glutathione in 50 mL water, adjusted to pH 7·0.
Results
The within-and between-batch precision and the linearity of the above assays are shown in Table 1 . The reference ranges for plasma 5-HIAA concentration and blood serotonin concentration were determined using non-parametric statistics and were found to be 27 to 70 nmol/L and 0'5 to 7' 0 nrnol/Iu? platelets. respectively. Receiver operator characteristic curve (ROC) analysis of the carcinoid patient samples and control samples (see Fig. 1 and Tables 2 and 3 ) showed no significant difference between blood serotonin, plasma 5-HIAA and urine 5-HIAA assays with regard to their diagnostic performance. However. the sensitivity and specificity of the three assays demonstrated considerable differences at the upper limits of their respective reference ranges, as shown in Table 4 . Whole blood serotonin was the most specific assay (100% specificity) but with considerably reduced sensitivity compared with 5-HIAA in plasma or urine. Plasma 5-HIAA showed the poorest specificity at a cut-off value of 70 nmol/L. However. by increasing the cut-off value for plasma 5-HIAA to 118 nmol/L, the assay specificity could be increased to 97% with no reduction in sensitivity. A comparison of all three assays at a specificity of 97% is shown in Table S . 158 (n=30) 50 (n=20) 1000 90 Table 1 . Discussion Table 2 
Intra-assay O/OCV
. Statistical information from the receiver operator curve analysis
The relationship between blood serotonin and plasma 5-HIAA is shown in Fig. 2 and demonstrates that platelets appear to become saturated with serotonin at about 40 nmol/Iu? platelets.
Samples for plasma 5-HIAA in the range of 37 to 700 nmol/L stored for 7 days at 4°C showed an average increase of 8%. The stability of blood serotonin with and without preservatives is shown in Fig. 3 . Plasma samples for 5-HIAA and blood for serotonin were routinely stored at -20°C prior to analysis.
Evidence-based research on diagnostic tests for carcinoid disease has been published by Meijer et aI. 5 They used a much larger group of 98 known carcinoid patients and compared the sensitivity and specificity of urine and platelet serotonin and 24-h urine 5-HIAA. With regard to midgut carcinoid patients, they found all three investigations to have a high discriminating function on ROC analysis. Platelet serotonin was shown to have the highest discriminating function overall and was recommended as the first line investigation for the detection of carcinoid disease. Whilst we obtained similar results for whole blood
Area SE serotonin and urine 5-HIAA assays, in addition we found that plasma S-HIAA assay, which was not studied by Meijer et al., also had a high discriminating function. However, our results show no significant difference between whole blood serotonin assay and plasma and urine 5-HIAA assays in their overall diagnostic discrimination in our carcinoid patient group (comprising primarily midgut tumours). Whilst whole blood serotonin was shown to have high specificity, its sensitivity was much reduced compared with that of urine or plasma S-HIAA assays. A reduction in the cut-off for whole blood serotonin concentration from 7·0 to 6·1 nmol/Iu? platelets only produced a slight improvement in sensitivity, from 75 to 77%. The high prevalence (44%) of carcinoid patients in this study is not representative of the patient population under investigation in normal clinical practice. An audit carried out by Tormey and Pltzgerald? found only four cases of carcinoid (all midgut) in 298 laboratory requests over a 5'S-year period. The prevalence of carcinoid in this study was calculated to be 1·3% of the patients being investigated for the disease. As carcinoid has a low prevalence in the patient 
Difference Contrast
Blood serotonin versus plasma 5-HIAA -0·038 Blood serotonin versus urine 5-HIAA -0·031 Plasma 5-HIAA versus urine 5-HIAA 0·007 population under investigation. a first-line test with a high sensitivity is required to ensure that few cases are missed. thus reducing the consequent morbidity associated with this condition. Although there was no overall significant difference in the discriminating function of the three assays in this study. at the upper limits of their respective reference ranges plasma 5-HIAA showed the highest sensitivity. However. its specificity was much reduced compared with whole blood serotonin and urine 5-HIAA assays. Increasing the cut-off value of plasma 5-HIAA from 70 to 118 nmol/L improves the specificity and test efficiency without any loss of sensitivity. The increased specificity for plasma 5-HIAA at this higher cut-off point should reduce the number of false positive tests. which would otherwise lead to an increased demand for diagnostic imaging services.
It is important that samples for plasma 5-HIAA concentration are collected in the fasting state or that serotonin-containing foods have been avoided for at least 8 h prior to blood collection. The measurement of plasma creatinine on samples with an elevated plasma 5-HIAA concentration is also important to exclude false positive increases due to renal impairment (unpublished data from this laboratory). The effect of renal disease on whole blood serotonin concentration also needs to be investigated.
As well as diagnosing carcinoid disease the laboratory has a role in monitoring the treatment of patients with this condition. The introduction of somatostatin analogues has considerably improved the quality of life of many carcinoid patlents.!" The saturability of serotonin in platelets shown in this study renders whole blood serotonin assay unsuitable for monitoring treatment. Further work is required to investigate the usefulness of plasma 5-HIAA assay in monitoring treatment.
In routine practice. the assay for plasma 5-HIAA concentration is technically more demanding than the urine 5-HIAA assay due to the pre-analytical extraction process. However. the measurement of plasma 5-HIAA concentration overcomes the problems associated with 24-h urine collections. Plasma 5-HIAA assay is also very stable. requiring no preservative or freezing within a set time period. in contrast to the blood serotonin assay.
This study suggests that plasma 5-HIAA may be suitable as a replacement for the long established measurement of 5-HIAA in 24-h urine collections. It also suggests that plasma 5-HIAA assay may be more efficient in the diagnosis of midgut carcinoids than whole blood serotonin assay. However. plasma 5-HIAA assay needs to be introduced into routine clinical practice to assess whether the same diagnostic . Serotonin was found to be unstable at room temperature after 24h without the addition ofa suitable preservative such as glutathione. It was recommended that all blood serotonin samples for this study be frozen as soon as possible after collection, preferably within 2 h. efficiency is achievable. Evaluation by other centres will also be useful to confirm the diagnostic efficiency of this test.
